|
Visual inspection:
during the investigation, no significant deformations or damage of the valve were determined.Permeability test:
a permeability test has shown that all components are permeable.Computer controlled test:
to investigate the claim of over-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valves are tested in both the horizontal as well as the vertical positions.The results show that the progav 2.0 operates within the accepted tolerance in the horizontal position.The shuntassistant 2.0 does not operate within the specified tolerances in the vertical position.An accelerated outflow of shuntassistant 2.0 was determined.Adjustment test:
the progav 2.0 was tested and is not adjustable.Braking force and brake function test:
the brake functionality test has shown that the brake function operates as expected.However, the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection:
after dismantling of the valves, deposits were found.Results:
the investigation showed accelerated outflow of the shuntassisstant 2.0, as well as an inability to adjust the progav 2.0.The visible deposits inside the valves led to the aforementioned functional impairments.Organic matter in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.A defect at the time of release can be excluded.The shunt system met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
|